473
Participants
Start Date
July 31, 2016
Primary Completion Date
December 31, 2021
Study Completion Date
July 31, 2022
ccfDNA analysis
The level of circulating ccfDNA, defined as extra cellular DNA, increases in CRC patients. The Inplex® method could validate the use of ccfDNA as a cancer biomarker in terms of prognosis and surveillance
Aurillac Hospital, Aurillac
Les Cèdres clinical, Brive-la-Gaillarde
Brive Hospital, Brivé
Gueret Hospital, Guéret
La marche clinical, Guéret
Sainte feyre Hospital, Sainte-Feyre
Perigueux clinical, Périgueux
Périgueux Hospital, Périgueux
Bergonie institute, Bordeaux
Bordeaux University Hospital, Bordeaux
Montpellier Institute, Montpellier
Montpellier University Hospital, Montpellier
Cahors Hospital, Cahors
Saint Antoine AP-HP, Paris
Saint Junien Hospital, Saint-Junien
Clermont Ferrand University Hospital, Clermont-Ferrand
Limoges Hospital, Limoges
Moulins Hospital, Moulins
Vichy Hospital, Vichy
University Hospital, Limoges
OTHER